Browsing: Biotech & Health

The clock is almost out. You have less than 24 hours left to apply to host a Side Event during TechCrunch Disrupt 2026. Applications close tonight at midnight PT.

The filing with the Securities and Exchange Commission on Thursday shows that Oura’s revenue has jumped substantially in the past year. The company went from $697 million in revenue during the nine-month period that ended June 30 last year to $1.2 billion during the corresponding period this year.

The Builders Stage is returning to TechCrunch Disrupt 2026, bringing together founders, startup operators, and investors for practical conversations on what it takes to build and scale successful companies.

It used to be that Vijay Pande was better known in academic circles than investor circles. That changed pretty abruptly a dozen years ago, when Marc Andreessen and Ben Horowitz — who’d spent their firm’s first five years explicitly avoiding healthcare and life sciences — decided the category was worth betting on after all and…